T2580000

托吡卡胺

Name: 托吡卡胺
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

同義詞:

N-Ethyl-2-phenyl-N-(4-pyridylmethyl)hydracrylamide, Ro 1-7683

Slide 1 of 1

登入查看組織和合約定價

選擇尺寸

暫時無法取得訂價和供貨情況

關於此項目

經驗公式（希爾表示法）:

C₁₇H₂₀N₂O₂

CAS 編號:

1508-75-4

分子量：:

284.35

MDL號碼:

MFCD00058580

分類程式碼代碼:

41116107

PubChem物質ID:

329826715

NACRES:

NA.24

重要文件

檢視所有文件

跳轉至

技術服務

需要援助？我們經驗豐富的科學家團隊隨時樂意為您提供支援。

讓我們為您提供幫助

等級

pharmaceutical primary standard

API 家族

tropicamide

製造商／商標名

EDQM

應用

pharmaceutical (small molecule)

形式

neat

儲存溫度

2-8°C

SMILES 字串

CCN(Cc1ccncc1)C(=O)C(CO)c2ccccc2

InChI

1S/C17H20N2O2/c1-2-19(12-14-8-10-18-11-9-14)17(21)16(13-20)15-6-4-3-5-7-15/h3-11,16,20H,2,12-13H2,1H3

InChI 密鑰

BGDKAVGWHJFAGW-UHFFFAOYSA-N

基因資訊

human ... CHRM3(1131)

尋找類似的產品？前往產品比較指南

比較類似項目

查看完整比較

Show Differences

1 of 4

本產品	1699005	BP1047	Y0001316
T2580000 托吡卡胺	USP 1699005 托吡卡胺	BP1047 托吡卡胺	Y0001316 托吡卡胺
grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade pharmaceutical primary standard
manufacturer/tradename EDQM	manufacturer/tradename USP	manufacturer/tradename BP	manufacturer/tradename EDQM
format neat	format neat	format neat	format neat
application(s) pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)	application(s) pharmaceutical pharmaceutical small molecule	application(s) pharmaceutical (small molecule)
API family tropicamide	API family tropicamide	API family tropicamide	API family tropicamide
storage temp. 2-8°C	storage temp. 2-8°C	storage temp. 2-8°C	storage temp. 2-8°C

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Tropicamide EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包裝

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他說明

Sales restrictions may apply.

象形圖

GHS07

訊號詞

Warning

危險聲明

H302 + H312 + H332,H315,H317,H319,H335

防範說明

P261 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338

危險分類

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

標靶器官

Respiratory system

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

從最近期的版本中選擇一個：

分析證明 (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如果您需要協助，請聯絡客戶支援

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Retinal blood flow and vascular reactivity in chronic smokers.

Kalpana Rose et al.

Investigative ophthalmology & visual science, 55(7), 4266-4276 (2014-05-08)

The aim of this study was to investigate the impact of cigarette smoking in otherwise healthy young individuals on retinal blood flow (RBF) and vascular reactivity (RVR). An automated gas flow controller (RespirAct) was used to achieve normoxic hypercapnia in

A novel murine model for keratoprosthesis.

Alja Crnej et al.

Investigative ophthalmology & visual science, 55(6), 3681-3685 (2014-05-17)

To establish a murine model for keratoprosthesis. A miniature keratoprosthesis (m-KPro) device was created consisting of a poly[methyl methacrylate] front part and a titanium back plate, designed after the Boston KPro, which is in widespread clinical use. BALB/c mice were

Ophthalmological consequences of cyanotic congenital heart disease: vascular parameters and nerve fibre layer.

Rachael Cordina et al.

Clinical & experimental ophthalmology, 43(2), 115-123 (2014-08-01)

This study investigated the long-term ophthalmological consequences of cyanotic congenital heart disease (CHD). Cross-sectional study, tertiary referral setting. Thirteen adults with cyanotic CHD (40 ± 4 years). Age- and sex-matched healthy controls underwent aspects of the protocol. Cyanosed subjects had a full

Fundus autofluorescence (FAF) non-invasively identifies chorioretinal toxicity in a rat model of retinal pigment epithelium (RPE) damage.

David Sung Hyeon Baek et al.

Journal of pharmacological and toxicological methods, 71, 77-82 (2014-09-10)

Traditional methods of pre-clinical ocular toxicology require that multiple cohorts of animals be sacrificed over time for terminal histological analysis. By contrast, in vivo techniques capable of following the same cohort prospectively have the potential to be efficient and cost-saving.

Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.

Jeeyun Ahn et al.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 29(7), 612-618 (2013-06-06)

To compare the pharmacokinetics (PKs) of intravitreally injected bevacizumab in vitrectomized versus nonvitrectomized control rabbit eyes. Twenty-five-gauge pars plana vitrectomy without lensectomy was performed in 17 right rabbit eyes (V) and 18 nonvitrectomized right rabbit eyes served as controls (C).

查看所有相關論文

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務